Ontology highlight
ABSTRACT: Background
Cell culture conditions during manufacturing can impact the clinical efficacy of chimeric antigen receptor (CAR) T cell products. Production methods have not been standardized because the optimal approach remains unknown. Separate CD4+ and CD8+ cultures offer a potential advantage but complicate manufacturing and may affect cell expansion and function. In a phase 1/2 clinical trial, we observed poor expansion of separate CD8+ cell cultures and hypothesized that coculture of CD4+ cells and CD8+ cells at a defined ratio at culture initiation would enhance CD8+ cell expansion and simplify manufacturing.Methods
We generated CAR T cells either as separate CD4+ and CD8+ cells, or as
SUBMITTER: Lee SY
PROVIDER: S-EPMC10660840 | biostudies-literature | 2023 Nov
REPOSITORIES: biostudies-literature